Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-11-20
1993-08-31
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514299, 546 93, 546 97, 546112, 546183, A61K 31435, C07D22122
Patent
active
052409350
ABSTRACT:
Novel substituted 2-azabicyclo[2.2.2]octane derivatives, pharmaceutical compositions containing them, methods for treating central nervous system disorders utilizing them, and processes for synthesizing them.
REFERENCES:
patent: 3422092 (1969-01-01), Moffett
patent: 3497518 (1970-02-01), Moffett
patent: 3741973 (1973-06-01), Fonken et al.
patent: 3780022 (1973-12-01), Fonken et al.
patent: 4180667 (1979-12-01), Michne
patent: 4563464 (1986-01-01), Ezer et al.
patent: 4808718 (1989-02-01), Hartman et al.
Michne, J. Org. Chem. 1976, 41(5), 894-896.
Buchi, et al., J. Am. Chem. Soc. 1966, 88(13), 3099-3109.
DeHaven-Hudkins Diane L.
Heimann Martha R.
Mallamo John P.
Michne William F.
Alexander Michael D.
Dentz Bernard
DuPont Paul E.
Sterling Winthrop Inc.
LandOfFree
Substituted 2-azabicyclo[2.2.2]octane derivatives and compositio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2-azabicyclo[2.2.2]octane derivatives and compositio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2-azabicyclo[2.2.2]octane derivatives and compositio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2297533